Upside Biotechnologies
Auckland · Founded 2016
About Upside Biotechnologies
Upside is developing the most advanced and best treatment for severe burns. The Upside product is a regenerative medicine solution to current shortcomings in the current treatment of severe burns patients. Upside will take a small sample of unburnt patient skin and grow it into differentiated, graftable skin in order to cover the patient’s own burns. Product advantages are that Upside's engineered skin is produced faster than any competitive pipeline product, it is supplied in bigger sheets and has good handling characteristics. Upside has intellectual property covering the processes conferring these specific advantages.
Company Facts
- Founded: 2016
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2017)
- Website: http://www.upside.nz/
- Phone: +64212460485
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/upside-biotechnologies-139498 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.